Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | TGM2 | P21980 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CTH | P32929 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | ECE1 | P42892 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.35 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.35 |
| ▸ | ITGAV | P06756 | 1/20 | 0.35 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.35 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.34 |
| ▸ | MME | P08473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL232856 | 1.00 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2POLBEGLN1MAPT | |
| SCHEMBL820926 | 0.85 | — | — | |
| SCHEMBL11100545 | 0.85 | — | — | |
| SCHEMBL820925 | 0.85 | — | — | |
| SCHEMBL9480613 | 0.85 | CNR2 (0.50) | ALDH1A1SMN1; SMN2POLBEGLN1MAPT | |
| SCHEMBL23140079 | 0.81 | TGM2 (0.40) | ALDH1A1SMN1; SMN2POLBTGM2APEX1 | |
| SCHEMBL23140062 | 0.81 | TGM2 (0.40) | ALDH1A1SMN1; SMN2POLBTGM2APEX1 | |
| SCHEMBL2159350 | 0.80 | — | — | |
| SCHEMBL24703252 | 0.79 | TGM2 (0.39) | ALDH1A1SMN1; SMN2TGM2APEX1CNR2 | |
| SCHEMBL10810547 | 0.79 | TGM2 (0.39) | ALDH1A1SMN1; SMN2TGM2APEX1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113325110-A | Method for determining specific organic acid by tandem mass spectrometry | 浙江大学 | 2021-08-31 | — | — | CN | claimed |
| CN-113156096-A | Blood-based biomarkers for diagnosing coronary atherosclerotic disease | 全球基因集团有限责任公司 | 2021-07-23 | — | — | CN | claimed |
| CN-106537145-B | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | disclosed |
| US-20250375505-A1 | COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM | UNIV CALIFORNIA (US) | 2025-12-11 | — | — | US | disclosed |
| CN-115677718-B | Methyl methylamine derivative preparation, pharmaceutical composition and application thereof | 武汉思瓴生物科技有限公司 | 2024-11-01 | — | — | CN | disclosed |
| US-11850440-B2 | Therapeutic systems using magnetic fields | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2023-12-26 | — | — | US | disclosed |
| CN-116672408-A | Application of Xinkuanning preparation in preparing medicine for treating arrhythmia and lipid metabolism abnormality | 陕西摩美得气血和制药有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-116194197-A | Resin composition for gas separation membrane and gas separation membrane | 住友化学株式会社 | 2023-05-30 | — | — | CN | disclosed |
| CN-116133740-A | Gas separation membrane and method for producing same | 住友化学株式会社 | 2023-05-16 | — | — | CN | disclosed |
| CN-115677718-A | Methylmethylamine derivative preparation, pharmaceutical composition and application thereof | 武汉思瓴生物科技有限公司 | 2023-02-03 | — | — | CN | disclosed |
| US-20120004854-A1 | METABOLIC BIOMARKERS FOR OVARIAN CANCER AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION | 2012-01-05 | — | — | US | disclosed |
| US-7993931-B1 | Oxygen-18 labeled organic acids and use in diagnosing metabolic disorders | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2011-08-09 | — | — | US | disclosed |
| WO-2011049150-A1 | PYRONE COMPOUND AND ITS USE FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-04-28 | — | — | WO | disclosed |
| WO-2011049150-A1 | PYRONE COMPOUND AND ITS USE FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-04-28 | — | — | WO | disclosed |
| US-20090197834-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2009-08-06 | — | — | US | disclosed |
| US-20090197834-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2009-08-06 | — | — | US | disclosed |
| EP-1995240-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Astellas Pharma Inc. (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-5342766-A | Culturing microorganism in an aqueous solution containing source of carbon, nitrogen and inorganic salts, recovering | TORAY INDUSTRIES, INC. (JP) | 1994-08-30 | — | — | US | disclosed |
| EP-0243496-A1 | PROCESS FOR PRODUCING L-THREONINE BY FERMENTATION | TORAY INDUSTRIES, INC. (JP) | 1987-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250375505-A1 | COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM | CYP27A1, LIPC, CYP46A1 | ALDH1A1 1661/4885SMN1; SMN2 4332/4885POLB 1663/4885 |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | IDO1, INMT, IDO2 | ALDH1A1 938/4885SMN1; SMN2 1923/4885POLB 4458/4885 |
| US-20090197834-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | P2RY12, P2RY11, P2RY10 | ALDH1A1 2376/4885SMN1; SMN2 4563/4885POLB 3393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.